Improving Gene Therapies for Muscular Dystrophies
Addressing Shortcomings of AAV GeneTherapies for the Muscular Dystrophies
This center is working to improve gene therapies for Duchenne and Limb Girdle Muscular Dystrophy, aiming to make them safer and more effective for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Florida NIH-funded |
| Lab location | 1 site (Gainesville, United States) |
| Project ID | NIH-11130228 on NIH RePORTER |
What this research studies
This research center is dedicated to making gene therapies better for people with Duchenne and Limb Girdle Muscular Dystrophy. We are creating new versions of gene therapy that can be delivered more effectively to muscles and the heart. Our work also focuses on reducing unwanted immune responses to these therapies, which can be a challenge with current treatments. We are testing these new approaches in lab models and plan to move towards human studies, including a clinical study to follow treated boys.
Who could benefit from this research
Good fit: This research is relevant for patients with Duchenne Muscular Dystrophy and Limb Girdle Muscular Dystrophy, especially those who might be candidates for gene therapy.
Not a fit: Patients without Duchenne or Limb Girdle Muscular Dystrophy would not directly benefit from this specific gene therapy approach.
Why it matters
Potential benefit: If successful, this work could lead to more effective and safer gene therapy options for individuals living with Duchenne and Limb Girdle Muscular Dystrophy.
How similar studies have performed: While AAV gene therapies are already being explored, this work aims to address known limitations and develop novel, improved approaches.
Where this research is happening
Gainesville, United States
- University of Florida — Gainesville, United States (Active)
Researchers
- Principal investigator: Sweeney, H Lee — University of Florida
- Study coordinator: Sweeney, H Lee
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.